Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Review article
Main Article Content
Abstract
The article presents results of the JUPITER Study (Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin) which assessed benefits of rosuvastatin therapy in apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)